UPC_OUT_1 [2025-04-16 13:06:20 -0400] 4942 Bytes | 1226 tokens | Cum: 1226 tkns (15.32% of 8k)
==========================================================================

You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Universe Pharmaceuticals (UPC) hit my radar screen, up to 4.3880 from a prev close of 3.3100 Do you think its got more juice or is it lacking potential? It's 1:06:19 PM on Wed Apr 16, 2025 -0400 and I have to decide: buy or sell!

--- COMPANY PROFILE ---
Company: Universe Pharmaceuticals (UPC)
IPO: 2021-03-23 (4 Years Ago)
Market Cap: $1,088,599
Shares Outstanding: 180,000
Exchange: XNAS
Description: Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Here’s a list of headlines for Universe Pharmaceuticals:

Mar-20-25 08:42AM - Universe Pharmaceuticals to conduct share consolidation
Mar-20-25 08:42AM 08:30AM - Universe Pharmaceuticals INC Announces Share Consolidation
Feb-25-25 04:10PM - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
Feb-03-25 04:10PM - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
Dec-10-24 05:00PM - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
Dec-09-24 07:00AM - Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
Nov-13-24 08:00AM - Universe Pharmaceuticals INC Announces Share Consolidation
Nov-01-24 04:00PM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Prior AI Reports for UPC:
1. 2025-04-04 – Score: 15 – Target: 3.5994 – Highs: 3.7341 / 3.3600 / 4.70
plummeting-sales-and-negative-returns-signal-tough-times-ahead
2. 2025-03-25 – Score: 20 – Target: 5.3000 – Highs: 5.6400 / 4.9700 / 5.36
universe-pharmaceuticals-faces-bleak-projections-amidst-steep-sales-decline
3. 2025-03-24 – Score: 15 – Target: 4.3000 – Highs: 4.3900 / 5.6400 / 4.97
universe-pharmaceuticals-declining-sales-performance-concerns-loom

(Note: Highs = Same day / 2nd day / 3rd day)

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2024-11-01T20:00:00Z - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
B2 - 2024-02-20T18:21:11Z - Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-02-20T13:09:16Z - Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
B4 - 2024-01-08T18:36:30Z - Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B5 - 2023-08-04T12:30:00Z - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
B6 - 2023-07-27T14:15:00Z - Universe Pharmaceuticals INC Announces Share Consolidation

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Universe Pharmaceuticals (UPC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

UPC_OUT_3 [2025-04-16 13:06:21 -0400] 933 Bytes | 231 tokens | Cum: 1459 tkns (18.24% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/11/01/2973531/0/en/Universe-Pharmaceuticals-INC-Receives-Nasdaq-Notification-Regarding-Minimum-Bid-Price-Deficiency.htmlUniverse Pharmaceuticals INC, a Chinese pharmaceutical company, received a notification from Nasdaq that it is not in compliance with the minimum bid price requirement for continued listing. The company has 180 days to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_5 [2025-04-16 13:06:22 -0400] 957 Bytes | 271 tokens | Cum: 1732 tkns (21.65% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-16T12:07:22Z - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Adaptive Biotechnologies (NASDAQ:AD...
A2 - 2025-04-04T17:06:22Z - 12 Health Care Stocks Moving In Friday's Intraday Session - Aldeyra Therapeutics (NASDAQ:ALDX), Adap...
A3 - 2025-04-01T17:05:47Z - 12 Health Care Stocks Moving In Tuesday's Intraday Session - bioAffinity Technologies (NASDAQ:BIAF),...
A4 - 2025-03-20T13:18:00Z - Universe Pharmaceuticals Plans To Effect Share Consolidation...
A5 - 2025-03-20T12:33:22Z - Universe Pharmaceuticals INC Announces Share Consolidation...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

UPC_OUT_7 [2025-04-16 13:06:22 -0400] 1181 Bytes | 341 tokens | Cum: 2075 tkns (25.94% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Adaptive Biotechnologies (NASDAQ:ADPT), Aptorum Gr (NASDAQ:APM)**Date: 2025-04-16Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44835988/12-health-care-stocks-moving-in-wednesdays-pre-market-sessionGainers icad ICAD shares increased by 72.0% to $3.32 during Wednesday's pre-market session. The company's market cap stands at $87.4 million. Universe Pharmaceuticals UPC stock increased by 17.82% to $3.9. The market value of their outstanding shares is at $59.3 million. Renovaro RENB stock rose 12.39% to $0.42. The market value of their outstanding shares is at $66.6 million. Assembly Biosciences ASMB shares increased by 10.09% to $10.8. The market value of their outstanding shares is at $81.0 million. Mira Pharmaceuticals MIRA shares moved upward

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_9 [2025-04-16 13:06:23 -0400] 1181 Bytes | 350 tokens | Cum: 2427 tkns (30.34% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): s by 9.06% to $0.98. The company's market cap stands at $16.2 million. China SXT Pharmaceuticals SXTC stock rose 8.81% to $1.85. The company's market cap stands at $25.4 million. Losers Forian FORA stock declined by 61.1% to $0.81 during Wednesday's pre-market session. The company's market cap stands at $25.2 million. BioCardia BCDA shares declined by 15.13% to $1.74. The company's market cap stands at $7.9 million. Syra Health SYRA stock decreased by 14.56% to $0.17. The market value of their outstanding shares is at $2.0 million. Adaptive Biotechnologies ADPT stock fell 13.44% to $6.7. The company's market cap stands at $988.7 million. Century Therapeutics IPSC stock decreased by 11.18% to $0.45. The market value of their outstanding shares is at $38.2 million. Aptorum Gr APM shares declined by 11.03% to $0.96. The market value of their outstanding shares is at $6.8 million. See Also:

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_11 [2025-04-16 13:06:24 -0400] 1102 Bytes | 359 tokens | Cum: 2788 tkns (34.85% of 8k)
==========================================================================

Showing A1 (chunk 3 of 3): www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADPTAdaptive Biotechnologies Corp$6.70-13.4%Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock - anytime.

Reveal Full ScoreEdge RankingsMomentum98.38Growth-Quality-Value31.01Price TrendShortMediumLongOverviewAPMAptorum Group Ltd$0.9645-10.7%ASMBAssembly Biosciences Inc$10.406.01%BCDABioCardia Inc$1.74-15.1%FORAForian Inc$0.8000-61.6%ICADicad Inc$3.2970.2%IPSCCentury Therapeutics Inc$0.4450-11.2%MIRAMira Pharmaceuticals Inc$0.94004.77%RENBRenovaro Inc$0.38192.22%SXTCChina SXT Pharmaceuticals Inc$1.710.59%SYRASyra Health Corp$0.1840-10.2%UPCUniverse Pharmaceuticals Inc$3.15-4.84%Market News and Data brought to you by Benzinga APIs

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

UPC_OUT_13 [2025-04-16 13:06:24 -0400] 238 Bytes | 59 tokens | Cum: 2849 tkns (35.61% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_OUT_15 [2025-04-16 13:06:31 -0400] 5026 Bytes | 1170 tokens | Cum: 4021 tkns (50.26% of 8k)
==========================================================================

This is our set of metrics for Universe Pharmaceuticals.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+------------------------+
| Volume: 93,910 | Perf Month: -0.16% | Option/Short: No / Yes | Sales Y/Y TTM: -22.33% |
+---------------------+-----------------------+------------------------+------------------------+
| Avg Volume: 348.02K | Perf Quarter: -81.73% | Short Float: 8.49% | ROE: -50.22% |
+---------------------+-----------------------+------------------------+------------------------+
| Rel Volume: 0.51 | Index: - | Short Ratio: 0.05 | ROI: -64.36% |
+---------------------+-----------------------+------------------------+------------------------+
| RSI (14): 44.30 | Market Cap: 0.83M | Short Interest: 0.02M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| ATR (14): 0.92 | Shs Outstand: 3.65M | Beta: 1.59 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA20: 2.03% | Shs Float: 0.21M | Sales Q/Q: -30.23% | P/E: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA50: -23.04% | Inst Own: 6.51% | Sales past 5Y: - | Earnings: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA200: -99.35% | Insider Own: 1.91% | Employees: - | |
+---------------------+-----------------------+------------------------+------------------------+
| Perf Week: 16.77% | Insider Trans: 0.00% | Debt/Eq: 0.24 | |
+---------------------+-----------------------+------------------------+------------------------+

The next section covers any insider trading by Universe Pharmaceuticals officers or majority shareholders (if available).

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.4061
Average Volume: 193389.33
30-Day High: 5.36
30-Day Low: 2.85
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Universe Pharmaceuticals (UPC).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Universe Pharmaceuticals.

2) MARKET_SCORE[]
This conversation was initiated because UPC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for UPC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, UPC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect UPC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Universe Pharmaceuticals.

11) ETHICAL_RATING[]
Rate Universe Pharmaceuticals’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Universe Pharmaceuticals.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

UPC_IN_17 [2025-04-16 13:06:32 -0400] 126 Bytes | 29 tokens | Cum: 4235 tkns (52.94% of 8k)
==========================================================================

====================================
[2025-04-16 13:06:32] # Analysis Completed
Elapsed Time: 13.03 seconds